韩国大学获新型PAK4降解诱导剂专利
Korean universities patent new PAK4 degradation inducers
生物技术与制药领域的最新动态
Korean universities patent new PAK4 degradation inducers
Novacell Technology reports new FPR2 agonists
Nippon Zoki Pharmaceutical synthesizes new GABA-A receptor subunit positive allosteric modulators
Novartis discovers new CDK inhibitors
Med-tech gainers and losers for Jan. 12-16, 2026
Regulatory actions for Jan. 20, 2026
Six drugs to watch in China for 2026
December blockbusters push biopharma deal value to record high
Early data lift Immunofoco’s solid tumor CAR T program
Holiday notice
Biggest gainers and losers for Jan. 12-16, 2026
Sundance Biosciences patents new TYK2 inhibitors for multiple sclerosis
University of Washington discovers HER2-targeting ADCs for cancer
Daewoong Pharmaceutical patents divulge new IRAK-4 inhibitors
Zincure synthesizes new MMP-9 inhibitors
Chong Kun Dang Pharmaceutical discovers new GLP-1R agonists
Negio Therapeutics patents α2-adrenoceptor agonists
Nanjing Chia Tai Tianqing Pharmaceutical identifies new somatostatin SST2 receptor agonists
Shenzhen Newrosetta Biosciences discloses new muscarinic M2 receptor antagonists
Immunitybio’s CAR-NK shows complete responses in Waldenström’s